CVR 21682977Public limited company (A/S)Engroshandel med læge- og hospitalsartikler (464620)HellerupFounded 19 Apr 1999
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about BIOGEN (DENMARK) A/S, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexEmployees
13
CVR, Aug 2026
0 (0%) over 12 months
Revenue
178.7M
DKK, annual report 2025
-23.6% on 2024
Result
+5.6M
DKK, annual report 2025
Equity
151.9M
DKK, annual report 2025
Biogen Netherlands B.V.100% of capital and votes, since 29 Dec 2008
Operating company
Dandex estimate: 13 employees registered in 2026Erik Magnus Bodinsince 31 Mar 2026
100% of capital and votesnotified 28 Dec 2008since 29 Dec 2008
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
Decided by Dandex with fixed rules from CVR and the filed annual reports, and for the auditor's report, the business model and the revenue model a calibrated decision model reading the report's text and the purpose clause, not registered by the company. Each label links to its definition.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
4 Oct 2012 to 15 Nov 2026.
19 Apr 1999 to 15 Nov 2026. Showing 25 of 26. The list above has every one.
Aug 2026, monthly: 13 employees, 13 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | Q1 2010 | Q2 2010 | Q3 2010 | Q4 2010 | 2011 | 2012 | 2013 | 2014 | Jan 2015 | Feb 2015 | Mar 2015 | Apr 2015 | May 2015 | Jun 2015 | Jul 2015 | Aug 2015 | Sep 2015 | Oct 2015 | Nov 2015 | Dec 2015 | Jan 2016 | Feb 2016 | Mar 2016 | Apr 2016 | May 2016 | Jun 2016 | Jul 2016 | Aug 2016 | Sep 2016 | Oct 2016 | Nov 2016 | Dec 2016 | Jan 2017 | Feb 2017 | Mar 2017 | Apr 2017 | May 2017 | Jun 2017 | Jul 2017 | Aug 2017 | Sep 2017 | Oct 2017 | Nov 2017 | Dec 2017 | Jan 2018 | Feb 2018 | Mar 2018 | Apr 2018 | May 2018 | Jun 2018 | Jul 2018 | Aug 2018 | Sep 2018 | Oct 2018 | Nov 2018 | Dec 2018 | Jan 2019 | Feb 2019 | Mar 2019 | Apr 2019 | May 2019 | Jun 2019 | Jul 2019 | Aug 2019 | Sep 2019 | Oct 2019 | Nov 2019 | Dec 2019 | Jan 2020 | Feb 2020 | Mar 2020 | Apr 2020 | May 2020 | Jun 2020 | Jul 2020 | Aug 2020 | Sep 2020 | Oct 2020 | Nov 2020 | Dec 2020 | Jan 2021 | Feb 2021 | Mar 2021 | Apr 2021 | May 2021 | Jun 2021 | Jul 2021 | Aug 2021 | Sep 2021 | Oct 2021 | Nov 2021 | Dec 2021 | Jan 2022 | Feb 2022 | Mar 2022 | Apr 2022 | May 2022 | Jun 2022 | Jul 2022 | Aug 2022 | Sep 2022 | Oct 2022 | Nov 2022 | Dec 2022 | Jan 2023 | Feb 2023 | Mar 2023 | Apr 2023 | May 2023 | Jun 2023 | Jul 2023 | Aug 2023 | Sep 2023 | Oct 2023 | Nov 2023 | Dec 2023 | Jan 2024 | Feb 2024 | Mar 2024 | Apr 2024 | May 2024 | Jun 2024 | Jul 2024 | Aug 2024 | Sep 2024 | Oct 2024 | Nov 2024 | Dec 2024 | Jan 2025 | Feb 2025 | Mar 2025 | Apr 2025 | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 5 | 7 | 10 | 12 | 11 | 15 | 13 | 13 | 12 | 14 | 14 | No count | No count | No count | No count | 19 | 17 | 25 | 30 | 32 | 33 | 32 | 31 | 31 | 31 | 31 | 31 | 30 | 29 | 29 | 29 | 27 | 30 | 29 | 26 | 25 | 24 | 24 | 23 | 25 | 24 | 24 | 26 | 26 | 26 | 32 | 26 | 27 | 27 | 27 | 29 | 29 | 29 | 29 | 29 | 28 | 30 | 29 | 29 | 26 | 26 | 25 | 24 | 25 | 24 | 22 | 21 | 21 | 21 | 21 | 20 | 22 | 21 | 21 | 22 | 23 | 23 | 23 | 23 | 23 | 23 | 22 | 23 | 24 | 23 | 23 | 24 | 26 | 27 | 27 | 28 | 28 | 28 | 25 | 26 | 27 | 25 | 25 | 24 | 23 | 22 | 23 | 23 | 22 | 23 | 21 | 21 | 22 | 23 | 25 | 23 | 22 | 22 | 20 | 19 | 20 | 22 | 22 | 21 | 20 | 20 | 20 | 20 | 20 | 19 | 19 | 18 | 18 | 18 | 16 | 16 | 16 | 15 | 14 | 13 | 13 | 14 | 14 | 14 | 13 | 14 | 14 | 13 | 14 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 14 | 14 | 14 | 14 | 14 | 14 | 13 | 13 |
| FTE | 2 | 7 | 7 | 12 | 14 | 13 | 15 | 14 | 17 | 17 | 18 | 18 | 18 | 19 | 20 | 22 | 25 | 23 | 26 | 31 | 31 | 30 | 28 | 28 | 28 | 29 | 28 | 29 | 28 | 28 | 28 | 26 | 28 | 28 | 25 | 23 | 23 | 23 | 23 | 24 | 23 | 24 | 26 | 26 | 26 | 26 | 26 | 26 | 27 | 27 | 29 | 28 | 28 | 28 | 28 | 27 | 29 | 28 | 28 | 26 | 25 | 25 | 24 | 25 | 23 | 22 | 21 | 21 | 20 | 21 | 20 | 21 | 21 | 21 | 22 | 22 | 22 | 23 | 23 | 23 | 23 | 22 | 23 | 24 | 23 | 23 | 24 | 26 | 26 | 26 | 28 | 27 | 28 | 24 | 25 | 27 | 24 | 23 | 23 | 22 | 22 | 23 | 23 | 22 | 22 | 21 | 21 | 22 | 23 | 24 | 22 | 21 | 21 | 19 | 18 | 19 | 20 | 21 | 20 | 19 | 20 | 20 | 20 | 19 | 19 | 19 | 18 | 18 | 17 | 16 | 16 | 15 | 15 | 14 | 13 | 13 | 14 | 14 | 14 | 13 | 14 | 14 | 13 | 14 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 14 | 14 | 14 | 14 | 14 | 13 | 13 |
| Series | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Quarterly | Quarterly | Quarterly | Quarterly | Annual | Annual | Annual | Annual | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's own headcount as CVR records it, not the annual report's average, which may cover a group. Annual 1999 to 2009 and 2011 to 2014; quarterly Q1 2010 to Q4 2010; monthly Jan 2015 to Aug 2026.
CVR changed its monthly method in Oct 2019, so a step at that month need not be real.
Latest Aug 2026, published 21 Oct 2026. Source: CVR employment series (Årsbeskæftigelse, Kvartalsbeskæftigelse, Månedsbeskæftigelse).
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 259,685 | 307,510 | 259,564 | 234,003 | 178,728 |
| Operating profit | +12,245 | +11,643 | +9,196 | +8,423 | +6,474 |
| Result for the year | +7,552 | +8,438 | +8,339 | +7,527 | +5,564 |
| Equity | 122,019 | 130,457 | 138,796 | 146,322 | 151,886 |
| Total assets | 243,158 | 160,344 | 198,578 | 191,112 | 187,240 |
| Employees (average) | 24 | 22 | 20 | 15 | 14 |
| Credit metrics (Dandex calculations) | |||||
| Revenue growth (omsætningsvækst) | -14.4% | 18.4% | -15.6% | -9.9% | -23.6% |
| EBIT margin (overskudsgrad) | 4.7% | 3.8% | 3.5% | 3.6% | 3.6% |
| EBITDA | 12,415note 1 | 11,780note 1 | 9,299note 1 | 8,484note 1 | 6,533note 1 |
| EBITDA margin (EBITDA-margin) | 4.8%note 1 | 3.8%note 1 | 3.6%note 1 | 3.6%note 1 | 3.7%note 1 |
| Employee growth (vækst i antal ansatte) | 0% | -8.3% | -9.1% | -25% | -6.7% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex (investeringer i anlægsaktiver) | 16note 2 | 15note 2 | 163note 2 | 0note 3 | 42note 2 |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages. Gearing and interest coverage are multiples. Rows marked Pro hold a value in the Pro plan. Definitions.
Annual report 2025
1 Jan 2025 to 31 Dec 2025, published 29 Jun 2026
Annual report 2024
1 Jan 2024 to 31 Dec 2024, published 27 Jun 2025
Annual report 2023
1 Jan 2023 to 31 Dec 2023, published 26 Jun 2024
Annual report 2022
1 Jan 2022 to 31 Dec 2022, published 28 Jun 2023
Annual report 2021
1 Jan 2021 to 31 Dec 2021, published 23 May 2022
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
The rows marked Pro on this page hold values in the Pro plan. For BIOGEN (DENMARK) A/S, that is:
Have Pro? Sign in to see the values on this page.
Each registered value from the day it took effect, newest first.
From CVR, read 15 Nov 2026. Text such as the signing rule and purpose is shown as registered.
From CVR, read 15 Nov 2026. A change is counted each time the registry records a new value, so a corrected address or an audit firm under a new entity counts too.
37 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Bestyrelse:
Fratrådte:
Morten Lofthus Tangnes, den 31.03.2026.
Tiltrådte:
Erik Magnus Bodin, den 31.03.2026.
Direktion:
Bestyrelse:
Fratrådte:
Louise Hammerich, den 01.12.2023.
Tiltrådte:
Morten Lofthus Tangnes, den 01.12.2023.
Direktion:
Fratrådte:
Louise Hammerich, (adm. dir), den 01.12.2023.
Tiltrådte:
Morten Lofthus Tangnes, den 01.12.2023.
Ny adresse: Strandvejen 125, 2900 Hellerup
Ny kommune: København
Bestyrelse:
Fratrådte:
Tashia Susana Lentz, den 01.12.2022.
Tiltrådte:
Louise Hammerich, den 01.12.2022.
Direktion:
Fratrådte:
Tashia Susana Lentz, (adm. dir), den 01.12.2022.
Tiltrådte:
Louise Hammerich, (adm. dir), den 01.12.2022.
Bestyrelse:
Fratrådte:
Ulf Johan Ström, den 31.08.2022.
Tiltrådte:
Sergio Ferreira da Silva Teixeira, den 01.09.2022.
Bestyrelse:
Fratrådte:
Janne Harder Holmelund, den 01.06.2021.
Tiltrådte:
Tashia Susana Lentz, den 01.06.2021.
Direktion:
Fratrådte:
Janne Harder Holmelund, (adm. dir), den 01.06.2021.
Tiltrådte:
Tashia Susana Lentz, (adm. dir), den 01.06.2021.
Ny adresse: Stationsparken 37, 3., 2600 Glostrup
Ny kommune: Glostrup
Bestyrelse:
Fratrådte:
Vesna Leskovsek Cizej, den 10.07.2017.
Tiltrådte:
Ulf Johan Ström, den 10.07.2017.
Bestyrelse:
Fratrådte:
Neil Raymond Sisak, den 01.03.2016, Steven John Green (formand), den 01.03.2016.
Tiltrådte:
Neil Raymond Sisak (formand), den 01.03.2016.
CVR-nummer:
21682977.
NAVN:
BIOGEN (DENMARK) A/S.
Adresse: Ørestads Boulevard 67, 1., 2300 København S.
Kommune: København.
Bestyrelse:
Fratrådte:
Thomas Lackner, den 01.07.2015.
Tiltrådte:
Vesna Leskovsek Cizej, den 01.07.2015.
CVR-nummer
21682977.
NAVN:
BIOGEN (DENMARK) A/S.
Adresse: Ørestads Boulevard 67, 1., 2300 København S.
Kommune: København.
Bestyrelse:
Fratrådte:
Thomas Francois Etienne Biet (formand), den 01.04.2015.
Tiltrådte:
Steven John Green (formand), den 01.04.2015.
CVR-nummer
21682977.
NAVN:
BIOGEN IDEC (DENMARK) A/S.
Adresse: Ørestads Boulevard 67, 1., 2300 København S.
Kommune: København.
Vedtægter ændret: 23.03.2015
Nyt navn: BIOGEN (DENMARK) A/S
Vedtægter ændret:
30.05.2014.
Direktion:
Udtrådt af direktionen:
Charlotte Leife, den 25.09.2012.
Indtrådt i direktionen:
Læge Janne Harder Holmelund (adm. dir), den 25.09.2012.
Bestyrelse:
Udtrådt af bestyrelsen:
Charlotte Leife, den 04.10.2012.
Indtrådt i bestyrelsen:
Læge Janne Harder Holmelund, den 04.10.2012, Allan Frank Fischer Petersen, den 04.10.2012.
Bestyrelse:
Udtrådt af bestyrelsen:
Peter Rützou-Hjelmkrone, den 14.05.2012.
Indtrådt i bestyrelsen:
Hr. Thomas Francois Etienne Biet (formand), den 14.05.2012.
Bestyrelse:
Udtrådt af bestyrelsen:
David Gregory Davis, den 04.03.2011.
Indtrådt i bestyrelsen:
Thomas Lackner, den 04.03.2011, Neil Raymond Sisak, den 04.03.2011.
Vedtægter ændret:
01.08.2009.
Vedtægter ændret:
29.12.2008.
Kapitalforhøjelse:
kr. 1.000,00 indbetalt kontant, kurs 3.683.000,00.
Kapitalen udgør herefter kr. 501.000,00.
Bestyrelse:
Udtrådt af bestyrelsen:
Johny Humaloja, den 30.09.2008.
Indtrådt i bestyrelsen:
Peter Rützou-Hjelmkrone, den 30.09.2008.
Revision:
Udtrådt af revisionen:
PricewaterhouseCoopers, Statsautoriseret Revisionsinteressentskab, den 30.06.2005.
Indtrådt i revisionen:
CVR-NR. 16994294 PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSAKTIESELSKAB, Strandvejen 44, 2900 Hellerup, den 30.06.2005.
Direktion:
Udtrådt af direktionen:
Francis Marsland, den 02.08.2005, Peter Rützou-Hjelmkrone, den 02.08.2005, Randolph Spicochi, den 02.08.2005.
Ny adresse:
Ørestads Boulevard 67, 1., 2300 København S.
Vedtægter ændret:
30.11.2004.
Bestyrelse:
Udtrådt af bestyrelsen:
Jean-Yves Boursier, den 30.11.2004, David Stephen Allsop, den 30.11.2004, Karl Anders Lundström, den 30.11.2004.
Indtrådt i bestyrelsen:
Peter Lindborg (formand), den 30.11.2004, Johny Humaloja, den 30.11.2004, Charlotte Leife, den 30.11.2004.
Direktion:
Udtrådt af direktionen:
Karl Anders Lundström, den 30.11.2004.
Indtrådt i direktionen:
Charlotte Leife (adm. dir), den 30.11.2004, Francis Marsland, den 30.11.2004, Peter Rützou-Hjelmkrone, den 30.11.2004, Randolph Spicochi, den 30.11.2004.
Selskabet tegnes af ét bestyrelsesmedlem alene eller af to direktører i forening.
Vedtægter ændret:
13.11.2003.
Nyt navn:
BIOGEN IDEC (DENMARK) A/S.
Bestyrelse:
Udtrådt af bestyrelsen:
Francis Paul Edward Marsland, den 13.11.2003.
Indtrådt i bestyrelsen:
David Stephen Allsop, den 13.11.2003.
Bestyrelse:
Udtrådt af bestyrelsen:
Patrick Volkert Jozef Johannes Vink, den 20.01.2003.
Indtrådt i bestyrelsen:
Francis Paul Edward Marsland, den 20.01.2003.
Bestyrelse:
Udtrådt af bestyrelsen:
James Henry Magnusen Kirkness, den 16.01.2002.
Indtrådt i bestyrelsen:
Patrick Volkert Jozef Johannes Vink (formand), den 16.01.2002.
Bestyrelse:
Udtrådt af bestyrelsen:
Peter Johan Lindborg, den 16.01.2001, Karen Lykke Sørensen, den 16.01.2001.
Indtrådt i bestyrelsen:
Karl Anders Lundström, den 16.01.2001.
Direktion:
Udtrådt af direktionen:
Karen Lykke Sørensen, den 16.01.2001.
Indtrådt i direktionen:
Karl Anders Lundström, den 16.01.2001.
Vedtægter ændret:
03.03.2000.
Ny adresse:
Lyngbyvej 28, 2100 København Ø.
Bestyrelse:
Udtrådt af bestyrelsen:
Tom Bork Petersen, den 03.03.2000.
Indtrådt i bestyrelsen:
Jean-Yves Boursier, den 03.03.2000, Karen Lykke Sørensen, den 03.03.2000.
Direktion:
Udtrådt af direktionen:
James Henry Magnusen Kirkness, den 03.03.2000.
Indtrådt i direktionen:
Karen Lykke Sørensen, den 03.03.2000.
Selskabet tegnes bestyrelsens formand alene eller af to bestyrelsesmedlemmer i forening eller et bestyrelsesmedlem og en direktør i forening.
Stiftelsesdato:
19.04.1999.
Seneste vedtægtsdato:
19.04.1999.
Kapital:
kr. 500.000,00.
Indbetalingsmåde:
kontant kr. 500.000,00 til kurs 100,00.
Stifter:
Biogen International B.V, den 19.04.1999.
Bestyrelse:
Tom Bork Petersen (formand), den 19.04.1999, James Henry Magnusen Kirkness, den 19.04.1999, Peter Johan Lindborg, den 19.04.1999.
Direktion:
James Henry Magnusen Kirkness, den 19.04.1999.
Selskabet tegnes af et bestyrelsesmedlem.
Revision:
PricewaterhouseCoopers, 2900 Hellerup, den 19.04.1999.
Første regnskabsår:
19.04.1999 - 31.12.1999.
Regnskabsår:
01.01 - 31.12.
1 registered in CVR.
P-number 1005121139Strandvejen 125, 2900 Hellerup
No other current company drawn.
No other current company drawn.
No other current company drawn.